Wellington Management Group’s 4D Molecular Therapeutics FDMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-247,471
| Closed | -$799K | – | 1949 |
|
|
2025
Q1 | $799K | Buy |
247,471
+70,192
| +40% | +$227K | ﹤0.01% | 1750 |
|
|
2024
Q4 | $987K | Buy |
177,279
+11,089
| +7% | +$61.8K | ﹤0.01% | 1706 |
|
|
2024
Q3 | $1.8M | Sell |
166,190
-13,254
| -7% | -$143K | ﹤0.01% | 1556 |
|
|
2024
Q2 | $3.77M | Buy |
179,444
+9,796
| +6% | +$206K | ﹤0.01% | 1379 |
|
|
2024
Q1 | $5.4M | Sell |
169,648
-10,827
| -6% | -$345K | ﹤0.01% | 1308 |
|
|
2023
Q4 | $3.66M | Buy |
180,475
+7,753
| +4% | +$157K | ﹤0.01% | 1373 |
|
|
2023
Q3 | $2.2M | Buy |
172,722
+3,638
| +2% | +$46.3K | ﹤0.01% | 1456 |
|
|
2023
Q2 | $3.06M | Sell |
169,084
-6,432
| -4% | -$116K | ﹤0.01% | 1394 |
|
|
2023
Q1 | $3.02M | Sell |
175,516
-85,188
| -33% | -$1.46M | ﹤0.01% | 1402 |
|
|
2022
Q4 | $5.79M | Sell |
260,704
-5,188
| -2% | -$115K | ﹤0.01% | 1234 |
|
|
2022
Q3 | $2.14M | Buy |
265,892
+143,508
| +117% | +$1.15M | ﹤0.01% | 1515 |
|
|
2022
Q2 | $855K | Hold |
122,384
| – | – | ﹤0.01% | 1705 |
|
|
2022
Q1 | $1.85M | Sell |
122,384
-139,563
| -53% | -$2.11M | ﹤0.01% | 1624 |
|
|
2021
Q4 | $5.75M | Buy |
+261,947
| New | +$5.75M | ﹤0.01% | 1428 |
|
|
2021
Q2 | – | Sell |
-90,251
| Closed | -$3.91M | – | 2171 |
|
|
2021
Q1 | $3.91M | Sell |
90,251
-118,928
| -57% | -$5.16M | ﹤0.01% | 1479 |
|
|
2020
Q4 | $8.67M | Buy |
+209,179
| New | +$8.67M | ﹤0.01% | 1217 |
|